NCT02169180
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Fukuoka, Japan
- Isehara, Japan
- Kobe, Japan
- Kyoto, Japan
Clinical trial condition
Lymphoma, Mantle-Cell
Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.
38 public trials
4 recruiting studies
Lymphoma, Mantle-Cell trial results
NCT00025662
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +31 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01367457
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
- Locations
-
- Complexo Hospitalario Universitario A Coruña A Coruña, Spain
- Hospital de La Santa Creu I Sant Pau Barcelona, Spain
- Hospital Vall D'Hebron Barcelona, Spain
- Hospital del Mar Barcelona, Spain
NCT00420056
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Brigham & Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- New York Presbyterian Hospital New York, United States
NCT00992134
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Department of Hematology, Ospedale San Bortolo Vicenza, VI, Italy
NCT00038623
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)
NCT04662255
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Alaska Oncology and Hematology, LLC Anchorage, Alaska, United States
- Arizona Oncology Associates, P.C. - HOPE Phoenix, Arizona, United States
- UCLA Medical Center Los Angeles, California, United States
- USO-Rocky Mountain Cancer Center Denver, Colorado, United States
Active, Not Recruiting
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
NCT04911478
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Blood and Marrow Transplant Program Palo Alto, California, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- Baylor Scott & White Research Institute Dallas, Texas, United States
- MD Anderson Caner Center Houston, Texas, United States